Paying for ZYDELIG

We know the challenges that can come with starting a new treatment. That's why we created ZYDELIG AccessConnect, a central resource of simple tools and services designed to help you access, afford, and adhere to ZYDELIG therapy.

Helping You Access ZYDELIG

QuickStart Coordination

Sometimes, there are unforeseen delays in determining insurance coverage. The ZYDELIG QuickStart program* offers a free 30-day supply of ZYDELIG for eligible patients experiencing an insurance coverage delay of more than 5 business days. There is no purchase obligation for participation in the QuickStart program.

Specialty Pharmacy Coordination

Our case specialists will work with your specialty pharmacy to help your ZYDELIG be delivered in a timely manner.

*Certain restrictions may apply

Helping You Afford ZYDELIG

Patients with private insurance

The ZYDELIG Co-pay Coupon Program may help eligible patients lower their out-of-pocket costs.

With a Co-pay Coupon, most eligible patients may pay no more than $5 per co-pay (restrictions apply).

  • Not valid for patients enrolled in government healthcare prescription drug programs, such as Medicare Part D and Medicaid. Patients in the coverage gap known as the "donut hole" also are not eligible.
  • The ZYDELIG Co-pay Coupon Program will cover the out-of-pocket costs for ZYDELIG prescriptions up to a maximum of 25% of the catalog price of ZYDELIG.

PATIENTS CAN CALL 1-844-6-ACCESS (1-844-622-2377) TO REGISTER OVER THE PHONE.

Co-pay Coupon Terms and Conditions

  • The ZYDELIG Co-pay Coupon Program will cover the out-of-pocket costs of a patient's ZYDELIG prescriptions after the patient pays the first $5 per prescription fill, up to a maximum of 25% of the catalog price of a 12-month supply of ZYDELIG. The card is valid for 12 months from the time received or 15 fills within that 12-month period.
  • The Gilead Co-pay Coupon Card ("Card") can be used only by eligible residents of the U.S., Puerto Rico, or U.S. territories at participating eligible retail, specialty, or mail-order pharmacies in the U.S., Puerto Rico, or U.S. territories. Product must originate in the U.S., Puerto Rico, or U.S. territories. You must be at least 18 years old to use the Card for yourself or a minor.
  • The Card is limited to one per person and is not transferable. No substitutions are permitted. The Card is only available with a valid prescription. The offer cannot be combined with any other coupon, free trial, discount, prescription savings card, or other offer. Patient may not be currently receiving free drug assistance through Gilead Sciences, Inc. ("Gilead")'s patient assistance programs.
  • The Card is not insurance and is not intended to substitute for insurance.
  • The Card is valid only for patients with commercial insurance or cash-pay patients and is not valid for prescriptions that are eligible to be reimbursed:
    • In whole or part by Medicare, Medicaid or a Medicare Part D plan, TRICARE, VA, DOD, Puerto Rico Government Health Insurance Plan ("Healthcare Reform"), or any other federal or state-funded healthcare benefit program (collectively, "Government Programs"); or
    • By commercial plans or other health or pharmacy benefit programs that reimburse for the entire cost of prescription drugs.
  • Patients without insurance coverage or who have commercial insurance that does not cover ZYDELIG are considered "cash-pay" patients. Medicare Part D enrollees who are in the prescription drug coverage gap (the "donut hole") are not considered cash-pay patients, and are not eligible for the co-pay coupon. Patients who begin receiving prescription benefits from such Government Programs at any time will no longer be eligible to use the Card. Void where prohibited by law, taxed, or restricted.
  • Patient, pharmacist, and prescriber agree not to seek reimbursement for all or any part of the benefit received by the patient through the offer. Both patient and pharmacist are each individually responsible for reporting receipt of coupon benefit to any insurer, health plan, or other third party who pays for or reimburses any part of the prescription filled using the Card, as required.
  • It is illegal to sell, purchase, trade, or counterfeit, or offer to sell, purchase, trade, or counterfeit the Card.
  • Certain information pertaining to your use of the Card will be shared with Gilead, the sponsor of the Card, and its affiliates. The information disclosed will include the date the prescription is filled, the number of pills or product dispensed by the pharmacists, and the amount of your co-pay that will be paid for by using the Card. For more information, please see the Gilead Privacy Policy at www.gilead.com.

Gilead reserves the right to terminate, rescind, revoke, or modify the Card at any time without notice.

Patients with prescriptions paid by government programs

AccessConnect can help patients with Medicare and Medicaid coverage identify independent foundations that offer eligible patients financial support.

Patients with no insurance coverage

For patients without insurance, AccessConnect case specialists can assess whether insurance coverage options may be available and if no insurance options exist, our Patient Assistance Program will determine if you meet the program eligibility requirements, including financial limits, to qualify to receive your medication free of charge.

Helping You Adhere to ZYDELIG

ZYDELIG AccessConnect Nurses will answer your questions and offer support designed to help you to stay with your therapy as prescribed.

Enrolling in ZYDELIG AccessConnect is simple. Visit zydeligaccessconnect.com and download the enrollment form or call toll-free at 1‑844‑6ACCESS (1‑844‑622‑2377) to get enrolled directly.

You can also complete and sign your enrollment form at your doctor's office or contact your specialty pharmacy for enrollment information.

Patient and Caregiver Resources

Staying informed about your disease and treatment can help you feel more confident in your fight.

See Patient Resources

Taking ZYDELIG

General Do's and Don'ts of taking ZYDELIG as well as general dosing information and what to do if you miss a dose.

Learn More

Important Safety Information

What is the most important information I should know about ZYDELIG?

ZYDELIG can cause serious side effects that can lead to death, including:

  • Liver problems. Abnormal liver blood test results are common during treatment with ZYDELIG. ZYDELIG can cause severe liver problems. Your doctor will do blood tests before and during your treatment with ZYDELIG to check for liver problems. Tell your doctor right away if you get yellowing of your skin or the white part of your eyes (jaundice), dark or brown (tea-colored) urine, pain in the upper right side of your stomach area (abdomen), or bleeding or bruising more easily than normal.
  • Severe diarrhea. Diarrhea is common during treatment with ZYDELIG and can sometimes be severe. Tell your doctor right away if the number of bowel movements you have in a day increases by 6 or more. Ask your doctor about medicines you can take to treat your diarrhea.
  • Lung or breathing problems. Your doctor may do tests to check your lungs if you have breathing problems during treatment with ZYDELIG. Tell your doctor right away if you get new or worsening cough, shortness of breath, difficulty breathing, or wheezing.
  • Infections. Tell your doctor right away if you have a fever or any signs of an infection while taking ZYDELIG.
  • Tear in intestinal wall (perforation). Tell your doctor or get medical help right away if you get new or worsening stomach area (abdomen) pain, chills, fever, nausea, or vomiting.
  • Severe skin reactions. Tell your doctor right away if you get painful sores or ulcers on your skin, lips, or in your mouth; a severe rash with blisters or peeling skin, or a rash with itching.

If you have any of the above serious side effects during treatment with ZYDELIG, your doctor may completely stop your treatment, stop your treatment for a period of time, or change your dose of ZYDELIG.

Who should not take ZYDELIG?

  • Those with a history of serious allergic or skin reactions, as determined by a doctor.

What are the other possible side effects of ZYDELIG?

ZYDELIG can cause serious side effects, including:

  • Serious allergic reaction. Tell your doctor or get medical help right away
  • Low white blood cell count (neutropenia). Neutropenia is common during treatment with ZYDELIG and can sometimes be severe. Your doctor will check your blood counts regularly during treatment with ZYDELIG. Tell your doctor right away if you have a fever or any signs of an infection.

The most common side effects of ZYDELIG when used in combination with Rituxan include pneumonia, fever, feeling tired, rash, cough, and nausea.

What should I tell my doctor before taking ZYDELIG?

  • All of your medical conditions, including if you have liver, lung, or breathing problems or an infection.
  • If you are pregnant or plan to become pregnant. ZYDELIG may harm your unborn baby. Women who are able to become pregnant should use effective birth control (contraception) during treatment with ZYDELIG and for at least 1 month after the last dose of ZYDELIG. Talk to your doctor about birth control methods. Tell your doctor right away if you become pregnant or think you are pregnant during treatment with ZYDELIG.
  • If you are breastfeeding or plan to breastfeed. You and your doctor should decide if you will take ZYDELIG or breastfeed. You should not do both.
  • All the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. ZYDELIG and certain other medicines may affect each other.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088. You can also call 1‑800‑GILEAD‑5 (1‑800‑445‑3235).

Please see full Prescribing Information, including Medication Guide with important warnings.

Gilead, the Gilead logo, ZYDELIG, the ZYDELIG logo, and AccessConnect are trademarks of Gilead Sciences, Inc., or one of its related companies. Other brands noted herein are the property of their respective owners. © 2017 Gilead Sciences, Inc. All rights reserved. ZYDC0182 (02/2017)